TX103

1 abstract

Abstract
Safety and efficacy of B7-H3 targeting CAR-T cell therapy for patients with recurrent GBM.
Org: Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, Beijing, China, Fuzhou Tcelltech Biological Science and Technology Inc., Fuzhou, China, Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China, Yale Cancer Center, New Haven, CT,